Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 11-12, 2009, Pages 4484-4491

  Boor, Peter ^a   Casper, Sandra ^b   Celec, Peter ^c   Hurbánková, Marta ^a   Beňo, Milan ^a   Heidland, August ^d   Amann, Kerstin ^b   Šebeková, Katarína ^a  

^a SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Physics and Informatics   (Slovakia)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

AOPP; Environmental pollutants; Fibrosis; Glomerulosclerosis; Oxidative stress; Passive smoking

Indexed keywords

AMOSITE; BIOLOGICAL MARKER; MESSENGER RNA;

ANIMAL; AORTA; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL; DRUG EFFECT; DUST; EXPOSURE; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; HUMAN; INDUSTRY; INFLAMMATION; KIDNEY; KIDNEY FUNCTION TEST; MALE; METABOLISM; OXIDATIVE STRESS; PASSIVE SMOKING; PATHOLOGY; PATHOPHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; AORTA; ASBESTOS, AMOSITE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD VESSELS; DUST; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; INDUSTRY; INFLAMMATION; INHALATION EXPOSURE; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, WISTAR; RNA, MESSENGER; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM; RATTUS; RATTUS NORVEGICUS;

EID: 71749084316     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00518.x     Document Type: Article

References (47)

1. Mallampalli A, Guntupalli KK. Smoking and systemic disease. Clin Occup Environ Med. 2006, 5:173-92. x
2. Freund KM, Belanger AJ, D'Agostino RB. The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol. 1993, 3:417-24.
3. Jee SH, Park J, Jo I. Smoking and atherosclerotic cardiovascular disease in women with lower levels of serum cholesterol. Atherosclerosis. 2007, 190:306-12.
4. Orth SR. Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. J Am Soc Nephrol. 2004, 15:S58-63.
5. Orth SR. Smoking and the kidney. J Am Soc Nephrol. 2002, 13:1663-72.
6. Raupach T, Schafer K, Konstantinides S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J. 2006, 27:386-92.
7. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997, 315:973-80.
8. Hu J, Ugnat AM. Active and passive smoking and risk of renal cell carcinoma in Canada. Eur J Cancer. 2005, 41:770-8.
9. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004, 45:S3-9.
10. Narkiewicz K. Second-hand smoke - a license to kill due to expire. Nephrol Dial Transplant. 2007, 22:1508-11.
11. Reid A, de Klerk N, Ambrosini GL. The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med. 2005, 62:885-9.
12. Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann N Y Acad Sci. 2002, 982:160-76.
13. Robledo R, Mossman B. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cell Physiol. 1999, 180:158-66.
14. Churg A, Tron V, Wright JL. Effects of cigarette smoke exposure on retention of asbestos fibers in various morphologic compartments of the guinea pig lung. Am J Pathol. 1987, 129:385-93.
15. Hecht SS. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new. Carcinogenesis. 2005, 26:1488-92.
16. Beno M, Hurbankova M, Dusinska M. Multinucleate cells (MNC) as sensitive semiquantitative biomarkers of the toxic effect after experimental fibrous dust and cigarette smoke inhalation by rats. Exp Toxicol Pathol. 2005, 57:77-87.
17. Kovacikova Z, Hurbankova M, Cerna S. Effect of exposure to ceramic fibres and cigarette smoke on antioxidant status of the lung. Neuro Endocrinol Lett. 2006, 27:23-6.
18. Witko-Sarsat V, Friedlander M, Nguyen Khoa T. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998, 161:2524-32.
19. Schinzel R, Munch G, Heidland A. Advanced glycation end products in end-stage renal disease and their removal. Nephron. 2001, 87:295-303.
20. Boor P, Konieczny A, Villa L. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant. 2007, 22:1323-31.
21. Sebekova K, Ramuscak A, Boor P. The selective TP receptor antagonist, S18886 (terutroban), attenuates renal damage in the double transgenic rat model of hypertension. Am J Nephrol. 2008, 28:47-53.
22. Amann K, Wolf B, Nichols C. Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells. Hypertension. 1997, 29:770-5.
23. Tornig J, Amann K, Ritz E. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol. 1996, 7:667-75.
24. Bokemeyer D, Panek D, Kramer HJ. In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol. 2002, 13:1473-80.
25. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005, 111:2684-98.
26. Whincup PH, Gilg JA, Emberson JR. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004, 329:200-5.
27. Black HR, Zeevi GR, Silten RM. Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron. 1983, 34:173-9.
28. Markowitz GS, Lin J, Valeri AM. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking. Hum Pathol. 2002, 33:826-35.
29. Oberai B, Adams CW, High OB. Myocardial and renal arteriolar thickening in cigarette smokers. Atherosclerosis. 1984, 52:185-90.
30. Nasr SH, D'Agati VD. Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol. 2007, 18:2032-6.
31. Liang KV, Greene EL, Oei LS. Nodular glomerulosclerosis: renal lesions in chronic smokers mimic chronic thrombotic microangiopathy and hypertensive lesions. Am J Kidney Dis. 2007, 49:552-9.
32. Culhaci N, Meteoglu I, Dundar M. Histopathological evaluation of renal vascular changes in rats exposed to passive smoking. Pathol Oncol Res. 2005, 11:121-4.
33. Arif JM, Vadhanam MV, De Groot AJ. Effect of cigarette smoke exposure on the modulation of 8-oxo-2'-deoxyguanosine in rat lungs as analyzed by 32P-postlabeling and HPLC-ECD. Int J Oncol. 2001, 19:763-6.
34. Gentry-Nielsen MJ, Top EV, Snitily MU. A rat model to determine the biomedical consequences of concurrent ethanol ingestion and cigarette smoke exposure. Alcohol Clin Exp Res. 2004, 28:1120-8.
35. Li HY, Hou FF, Zhang X. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol. 2007, 18:528-38.
36. Shi XY, Hou FF, Niu HX. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology. 2008, 149:1829-39.
37. Wang Y, Wang Y, Cai Q. By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol. 2008, 172:1491-9.
38. Bachi A, Zuccato E, Baraldi M. Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immuno-affinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Radic Biol Med. 1996, 20:619-24.
39. Visioli F, Galli C, Plasmati E. Olive phenol hydroxytyrosol prevents passive smoking-induced oxidative stress. Circulation. 2000, 102:2169-71.
40. Flores L, Vidal M, Abian J. The effects of smoking and its cessation on 8-epi-PGF2alpha and transforming growth factor-beta 1 in type 1 diabetes mellitus. Diabet Med. 2004, 21:285-9.
41. Park EM, Park YM, Gwak YS. Oxidative damage in tissues of rats exposed to cigarette smoke. Free Radic Biol Med. 1998, 25:79-86.
42. Wang Z, Nicholls SJ, Rodriguez ER. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 2007, 13:1176-84.
43. Cerna S, Beno M, Hurbankova M. Evaluation of bronchoalveolar lavage fluid cytotoxic parameters after inhalation exposure to amosite and wollastonite fibrous dusts combined with cigarette smoke. Cent Eur J Public Health. 2004, 12:S20-3.
44. Miserocchi G, Sancini G, Mantegazza F. Translocation pathways for inhaled asbestos fibers. Environ Health. 2008, 7:4.
45. Dement JM, Brown DP, Okun A. Follow-up study of chrysotile asbestos textile workers: cohort mortality and case-control analyses. Am J Ind Med. 1994, 26:431-47.
46. Hein MJ, Stayner LT, Lehman E. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med. 2007, 64:616-25.
47. IA EL-S, Gadallah M, Shouman AE. Subclinical nephrotoxicity caused by smoking and occupational silica exposure among Egyptian industrial workers. Arch Med Res. 2003, 34:415-21.